Skip to main content
. 2020 Jul 10;15:16–22. doi: 10.1016/j.phro.2020.06.008

Fig. 4.

Fig. 4

A case-by-case comparison between both planning strategies, oriented towards radiobiological risk. Individual values are based on EQD2-adjusted cumulative dose distributions (with an α-β-ratio of 3). Threshold values and their clinical endpoints are listed in Supplementary Table S3.